Article Details
Retrieved on: 2021-12-28 12:07:05
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
12/21, Truist Securities Adjusts Price Target on NuVasive to $60 From $75, Maintains Buy Rating. MT. 12/10, RBC Initiates NuVasive at Outperform ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here